We are interested in cell biology, molecular mechanisms, and the pathogenesis of cancers and aim to develop novel therapeutic strategies for treating cancers.
- De novo design of nanobodies to target essential molecules in cancer progression and collaborates with clinicians and biotech companies to develop nanobody drugs for treating cancers.
2. We explore the drug resistance mechanisms of advanced lung cancer via tumor microenvironment-mimicking organoids.
3. Studying the role of recycling endosomes in cancer pathogenesis.
PHChen Laboratory 